Resources

This webinar is part of a series of capacity-building webinars to enhance national NTD program supply chain competences and create space for cross-country experience sharing.

The United States Agency for International Development (USAID) granted funding to FHI 360 for the implementation of Act to End Neglected Tropical Disease West (Act | West) program from July 19, 2018–July 18, 2023. The program is part of the global effort to eliminate neglected tropical diseases (NTDs). It particularly aims to eliminate lymphatic filariasis (LF), trachoma, and onchocerciasis (OV) (in certain countries) and control schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) in 11 endemic West African countries—including Burkina Faso, Benin, Cameroon, Guinea, Ghana, Côte D’Ivoire, Mali, Niger, Senegal, Sierra Leone, and Togo. It also supports achievement of sustainable service delivery, with growing ownership of national governments in the elimination and/or control of NTDs. This report outlines the key achievements and challenges in the first six months of the second year of program implementation, spanning the period April 1, 2020–September 30, 2020.

This report outlines the key achievements and challenges in the first six months of the second year of implementation of USAID's Act to End NTDs | West Program, spanning the period October 1, 2019–March 31, 2020.

This brochure summarizes the work of USAID's Act to End NTDs | West Program, providing a big picture look at program activities and progress to date as we continue taking action to disrupt the damage of debilitating diseases of poverty. Built on a foundation of broad international cooperation and implemented by a strong consortium of deeply committed partners, led by FHI 360, Act | West works closely with the governments of 11 African countries to eliminate and control five of the world’s most common NTDs over the long term.

USAID's Act to End NTDs | West program will support the elimination of neglected tropical diseases (NTDs) in Benin, Burkina Faso, Cameroon, Ghana, Guinea, Cote d’Ivoire, Mali, Niger, Senegal, Sierra Leone and Togo. The program seeks to build upon the achievements of the END in Africa and ENVISION projects in West Africa in their efforts to eliminate lymphatic filariasis (LF) and trachoma as public health problems, and onchocerciasis (OV) in selected countries. It aims to enable Neglected Tropical Disease programs (NTDPs) to sustain treatment for long-term control programs for schistosomiasis (SCH), soil-transmitted helminths (STH) and OV and to mainstream NTDPs into the national health system. The Act to End NTDs | West FY2020 Work Plan is built upon the accumulated experience and lessons learned in NTD programs in West Africa and the current program’s first year of implementation, directly by FHI 360 or in collaboration with our partners.

The FY2020 work plan outlines the activities that are expected to be undertaken in Cote d'Ivoire in the next fiscal year through USAID's Act to End NTDs | West program (Act | West), led and implemented in Cote d'Ivoire by FHI 360.

The USAID Act to End NTDs | West program's two-phase gender analysis examines the differential impact of NTDs by gender, including how gender norms and power differentials may impact NTD program results and how the program can help advance gender equality. Phase one of the gender analysis consists of a literature review, drawing on published and grey literature, as well as an initial analysis of available quantitative data.

It’s no secret that men and women don’t always have equal access to health services, so USAID’s NTD Programs recently studied gender balance in mass drug administration for NTDs.